Boulder, CO – According to filings with the U.S. Securities and Exchange Commission, Somalogic is raising $102,974,957.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Roy Smythe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Somalogic

SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Building on the previous decade of aptamer research, SomaLogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences. Our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare.

To learn more about Somalogic, visit http://www.somalogic.com/

Contact:
Roy Smythe, Chief Executive Officer
303-625-9000
https://www.linkedin.com/in/roy-smythe-m-d-4855a542/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved